Skip to content

RLAY · Relay Therapeutics, Inc.

Healthcare · −5.9% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 6 feeds behind: Insider filings, 4 days, and 5 more · Every feed →

On this page

The market view

Price chart

The interactive RLAY chart (by TradingView) loads here.

Our take

2 rules fired on RLAY

In short: none of these rules has solid or some evidence yet, so they show no clear lean on RLAY.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

The 0–100 score for RLAY, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on RLAY, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of RLAY. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 23, 2026–Oct 20, 2026 · UTC dates · today is excluded

Insider sales

Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual.

Latest 28 days
2
Earlier median
4
Earlier range
4–7
Distinct filers per 28 daysScale: 0–7
Oct 22, 2025Oct 20, 2026
Earlier periodsLatest 28 daysEarlier median 4Limited or missing history

Who appears in the latest period?

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Jun 24, 2026. Newest disclosure across this feed: Oct 16, 2026.

Earlier periods in the comparison: 3. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 22, 2025–Nov 18, 2025—Unavailable
Nov 19, 2025–Dec 16, 2025—Unavailable
Dec 17, 2025–Jan 13, 2026—Unavailable
Jan 14, 2026–Feb 10, 2026—Unavailable
Feb 11, 2026–Mar 10, 2026—Unavailable
Mar 11, 2026–Apr 7, 2026—Unavailable
Apr 8, 2026–May 5, 2026—Unavailable
May 6, 2026–Jun 2, 2026—Unavailable
Jun 3, 2026–Jun 30, 20260Partial; excluded
Jul 1, 2026–Jul 28, 20260Within stored history
Jul 29, 2026–Aug 25, 20260Within stored history
Aug 26, 2026–Sep 22, 20260Within stored history
Sep 23, 2026–Oct 20, 2026Latest period0Within stored history
Insider sales · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 4; range: 4–7.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 22, 2025–Nov 18, 2025—Unavailable
Nov 19, 2025–Dec 16, 2025—Unavailable
Dec 17, 2025–Jan 13, 2026—Unavailable
Jan 14, 2026–Feb 10, 2026—Unavailable
Feb 11, 2026–Mar 10, 2026—Unavailable
Mar 11, 2026–Apr 7, 2026—Unavailable
Apr 8, 2026–May 5, 2026—Unavailable
May 6, 2026–Jun 2, 2026—Unavailable
Jun 3, 2026–Jun 30, 20262Partial; excluded
Jul 1, 2026–Jul 28, 20264Within stored history
Jul 29, 2026–Aug 25, 20264Within stored history
Aug 26, 2026–Sep 22, 20267Within stored history
Sep 23, 2026–Oct 20, 2026Latest period2Within stored history
Congress purchases · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 22, 2025–Nov 18, 2025—Unavailable
Nov 19, 2025–Dec 16, 2025—Unavailable
Dec 17, 2025–Jan 13, 2026—Unavailable
Jan 14, 2026–Feb 10, 2026—Unavailable
Feb 11, 2026–Mar 10, 2026—Unavailable
Mar 11, 2026–Apr 7, 2026—Unavailable
Apr 8, 2026–May 5, 2026—Unavailable
May 6, 2026–Jun 2, 2026—Unavailable
Jun 3, 2026–Jun 30, 2026—Unavailable
Jul 1, 2026–Jul 28, 2026—Unavailable
Jul 29, 2026–Aug 25, 2026—Unavailable
Aug 26, 2026–Sep 22, 2026—Unavailable
Sep 23, 2026–Oct 20, 2026Latest period—Unavailable
Congress sales · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 22, 2025–Nov 18, 2025—Unavailable
Nov 19, 2025–Dec 16, 2025—Unavailable
Dec 17, 2025–Jan 13, 2026—Unavailable
Jan 14, 2026–Feb 10, 2026—Unavailable
Feb 11, 2026–Mar 10, 2026—Unavailable
Mar 11, 2026–Apr 7, 2026—Unavailable
Apr 8, 2026–May 5, 2026—Unavailable
May 6, 2026–Jun 2, 2026—Unavailable
Jun 3, 2026–Jun 30, 2026—Unavailable
Jul 1, 2026–Jul 28, 2026—Unavailable
Jul 29, 2026–Aug 25, 2026—Unavailable
Aug 26, 2026–Sep 22, 2026—Unavailable
Sep 23, 2026–Oct 20, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

Owners & lobbying

Insiders · Oct 2026

  1. Disclosed
    Sanjiv Patel · Sale

    Transaction dated Oct 7, 2026

  2. Disclosed
    Thomas Catinazzo · Sale

    Transaction dated Oct 6, 2026

  3. Disclosed
    Thomas Catinazzo · Sale

    Transaction dated Oct 6, 2026

  4. Filed
  5. Filed
All 36 records in this snapshot
  1. Disclosed
    Sanjiv Patel · Sale

    Transaction dated Oct 7, 2026

  2. Disclosed
    Thomas Catinazzo · Sale

    Transaction dated Oct 6, 2026

  3. Disclosed
    Thomas Catinazzo · Sale

    Transaction dated Oct 6, 2026

  4. Filed
  5. Filed
  6. Disclosed
    Donald A Bergstrom · Sale

    Transaction dated Sep 8, 2026

  7. Disclosed
    Sanjiv Patel · Sale

    Transaction dated Sep 8, 2026

  8. Disclosed
    Thomas Catinazzo · Sale

    Transaction dated Sep 8, 2026

  9. Disclosed
    Peter Rahmer · Sale

    Transaction dated Aug 26, 2026

  10. Disclosed
    Sb Investment Advisers (Uk) Ltd · Sale

    Transaction dated Aug 25, 2026

  11. Disclosed
    Softbank Vision Fund (Aiv M2) L.P. · Sale

    Transaction dated Aug 25, 2026

  12. Disclosed
    SVF Pauling (Cayman) Ltd · Sale

    Transaction dated Aug 25, 2026

  13. Filed
  14. Filed
  15. Disclosed
    Sanjiv Patel · Sale

    Transaction dated Aug 17, 2026

  16. Disclosed
    Thomas Catinazzo · Sale

    Transaction dated Aug 14, 2026

  17. Filed
  18. Filed
  19. Disclosed
    Donald A Bergstrom · Sale

    Transaction dated Jul 28, 2026

  20. Disclosed
    Peter Rahmer · Sale

    Transaction dated Jul 28, 2026

  21. Disclosed
    Thomas Catinazzo · Sale

    Transaction dated Jul 28, 2026

  22. Disclosed
    Donald A Bergstrom · Sale

    Transaction dated Jul 6, 2026

  23. Disclosed
    Sanjiv Patel · Sale

    Transaction dated Jul 7, 2026

  24. Disclosed
    Thomas Catinazzo · Sale

    Transaction dated Jul 6, 2026

  25. Disclosed
    Peter Rahmer · Sale

    Transaction dated Jun 30, 2026

  26. Disclosed
    Donald A Bergstrom · Sale

    Transaction dated Jun 22, 2026

  27. Disclosed
    Thomas Catinazzo · Sale

    Transaction dated Jun 22, 2026

  28. Disclosed
    Thomas Catinazzo · Sale

    Transaction dated Jun 22, 2026

  29. Disclosed
    Thomas Catinazzo · Sale

    Transaction dated Jun 22, 2026

  30. Disclosed
    Thomas Catinazzo · Sale

    Transaction dated Jun 22, 2026

  31. Filed
  32. Filed
  33. Filed
  34. Filed
  35. Record date
  36. Filed

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on RLAY disclosed in the last 90 days.

See every Congress trade on RLAY →

Company insiders

0 buys · 14 sells (15 filed lots) · $353M sold

  1. ▼ SELLThomas Catinazzo Chief Financial OfficerRLAY Relay Therapeutics, Inc.$4Kdisclosed Oct 8 · filed 2 days after the trade
  2. ▼ SELLThomas Catinazzo Chief Financial OfficerRLAY Relay Therapeutics, Inc.$325Kdisclosed Oct 8 · filed 2 days after the trade
  3. ▼ SELLSanjiv Patel President and CEORLAY Relay Therapeutics, Inc.$872Kdisclosed Oct 8 · filed 1 day after the trade
  4. ▼ SELLDonald A Bergstrom President, R&DRLAY Relay Therapeutics, Inc.$162Kdisclosed Sep 9 · filed 1 day after the trade
  5. ▼ SELLThomas Catinazzo Chief Financial OfficerRLAY Relay Therapeutics, Inc.$336Kdisclosed Sep 9 · filed 1 day after the trade
  6. ▼ SELLSanjiv Patel President and CEORLAY Relay Therapeutics, Inc.$913Kdisclosed Sep 9 · filed 1 day after the trade
  7. ▼ SELLSb Investment Advisers (Uk) Ltd 10% ownerRLAY Relay Therapeutics, Inc.$116Mdisclosed Aug 28 · filed 3 days after the trade
  8. ▼ SELLPeter Rahmer InsiderRLAY Relay Therapeutics, Inc.$90.3Kdisclosed Aug 28 · filed 2 days after the trade
  9. ▼ SELLSoftbank Vision Fund (Aiv M2) L.P. 10% ownerRLAY Relay Therapeutics, Inc.$116Mdisclosed Aug 28 · filed 3 days after the trade
  10. ▼ SELLSVF Pauling (Cayman) Ltd 10% ownerRLAY Relay Therapeutics, Inc.$116Mdisclosed Aug 28 · filed 3 days after the trade
See every insider trade on RLAY →

Big holders (Schedule 13D / 13G): 1 filing in the last 90 days · newest: Fmr LLC (13G), Aug 6, 2026 ↗

Filings & events

Company filings (8-K) 59

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Shared information with investors · item 7.0110
  • Quarterly or yearly results · item 2.029
  • Other events · item 8.017
  • Shareholder vote results · item 5.073
  • Changed its charter or bylaws · item 5.032
  • Signed a major agreement · item 1.012

Filing red flags 9

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

Planned insider sales (Form 144) 39

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

8 in the last 90 days · 39 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 5

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 0 filings
  • 13G, just holds: 5 filings

Filed most: Perceptive Advisors LLC (2) · Fmr LLC (1) · Commodore Capital LP (1) · Point72 Asset Management, L.P. (1)

Biggest named funds (13F)

The largest RLAY holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on RLAY

  1. ▼ SELLThomas Catinazzo Chief Financial OfficerRLAY Relay Therapeutics, Inc.$4Kdisclosed Oct 8 · filed 2 days after the trade
  2. ▼ SELLThomas Catinazzo Chief Financial OfficerRLAY Relay Therapeutics, Inc.$325Kdisclosed Oct 8 · filed 2 days after the trade
  3. ▼ SELLSanjiv Patel President and CEORLAY Relay Therapeutics, Inc.$872Kdisclosed Oct 8 · filed 1 day after the trade
  4. ▼ SELLDonald A Bergstrom President, R&DRLAY Relay Therapeutics, Inc.$162Kdisclosed Sep 9 · filed 1 day after the trade
  5. ▼ SELLThomas Catinazzo Chief Financial OfficerRLAY Relay Therapeutics, Inc.$336Kdisclosed Sep 9 · filed 1 day after the trade
  6. ▼ SELLSanjiv Patel President and CEORLAY Relay Therapeutics, Inc.$913Kdisclosed Sep 9 · filed 1 day after the trade
  7. ▼ SELLSb Investment Advisers (Uk) Ltd 10% ownerRLAY Relay Therapeutics, Inc.$116Mdisclosed Aug 28 · filed 3 days after the trade
  8. ▼ SELLPeter Rahmer InsiderRLAY Relay Therapeutics, Inc.$90.3Kdisclosed Aug 28 · filed 2 days after the trade
  9. ▼ SELLSoftbank Vision Fund (Aiv M2) L.P. 10% ownerRLAY Relay Therapeutics, Inc.$116Mdisclosed Aug 28 · filed 3 days after the trade
  10. ▼ SELLSVF Pauling (Cayman) Ltd 10% ownerRLAY Relay Therapeutics, Inc.$116Mdisclosed Aug 28 · filed 3 days after the trade
  11. ▼ SELLSanjiv Patel President and CEORLAY Relay Therapeutics, Inc.$980Kdisclosed Aug 18 · filed 1 day after the trade
  12. ▼ SELLThomas Catinazzo Chief Financial OfficerRLAY Relay Therapeutics, Inc.$350Kdisclosed Aug 18 · filed 4 days after the trade
  13. ▼ SELLPeter Rahmer InsiderRLAY Relay Therapeutics, Inc.$13.9Kdisclosed Jul 30 · filed 2 days after the trade
  14. ▼ SELLThomas Catinazzo Chief Financial OfficerRLAY Relay Therapeutics, Inc.$27.2Kdisclosed Jul 30 · filed 2 days after the trade
  15. ▼ SELLDonald A Bergstrom President, R&DRLAY Relay Therapeutics, Inc.$41.6Kdisclosed Jul 30 · filed 2 days after the trade
  16. ▼ SELLThomas Catinazzo Chief Financial OfficerRLAY Relay Therapeutics, Inc.$331Kdisclosed Jul 8 · filed 2 days after the trade
  17. ▼ SELLDonald A Bergstrom President, R&DRLAY Relay Therapeutics, Inc.$162Kdisclosed Jul 8 · filed 2 days after the trade
  18. ▼ SELLSanjiv Patel President and CEORLAY Relay Therapeutics, Inc.$944Kdisclosed Jul 8 · filed 1 day after the trade
  19. ▼ SELLPeter Rahmer InsiderRLAY Relay Therapeutics, Inc.$955Kdisclosed Jul 2 · filed 2 days after the trade
  20. ▼ SELLThomas Catinazzo Chief Financial OfficerRLAY Relay Therapeutics, Inc.$1Mdisclosed Jun 24 · filed 2 days after the trade
  21. ▼ SELLThomas Catinazzo Chief Financial OfficerRLAY Relay Therapeutics, Inc.$301Kdisclosed Jun 24 · filed 2 days after the trade
  22. ▼ SELLThomas Catinazzo Chief Financial OfficerRLAY Relay Therapeutics, Inc.$956Kdisclosed Jun 24 · filed 2 days after the trade
  23. ▼ SELLDonald A Bergstrom President, R&DRLAY Relay Therapeutics, Inc.$1.6Mdisclosed Jun 24 · filed 2 days after the trade
  24. ▼ SELLThomas Catinazzo Chief Financial OfficerRLAY Relay Therapeutics, Inc.$875Kdisclosed Jun 24 · filed 2 days after the trade
See the trades on RLAY in the feed →
People & votes

Which members of Congress traded RLAY, sponsored bills that touch it and voted on them — opens here.